Form 8-K - Current report:
SEC Accession No. 0001104659-25-055143
Filing Date
2025-06-02
Accepted
2025-06-02 06:13:18
Documents
17
Period of Report
2025-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516831d1_8k.htm   iXBRL 8-K 56065
2 EXHIBIT 2.1 tm2516831d1_ex2-1.htm EX-2.1 926347
3 EXHIBIT 99.1 tm2516831d1_ex99-1.htm EX-99.1 45326
7 GRAPHIC tm2516831d1_ex99-1img001.jpg GRAPHIC 3371
8 GRAPHIC tm2516831d1_ex99-1img002.jpg GRAPHIC 1390
9 GRAPHIC tm2516831d1_ex99-1img003.jpg GRAPHIC 3258
  Complete submission text file 0001104659-25-055143.txt   1425421

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20250602.xsd EX-101.SCH 3044
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20250602_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20250602_pre.xml EX-101.PRE 22378
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2516831d1_8k_htm.xml XML 3569
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 251013046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)